{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:44:39Z","timestamp":1789962279226,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtocrr.2024.100653","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:39:47Z","timestamp":1708465187000},"page":"100653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["RET Fusion Testing in Patients With NSCLC: The RETING Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Esther","family":"Conde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Rodriguez Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Curto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Caminoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Clave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"Arriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Esteban-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sansano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00f3mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Abdulkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Teixido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Reguart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desamparados","family":"Compa\u00f1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Insa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Manche\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Palanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Juan-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Baixeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cebollero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartomeu","family":"Massuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lopez-Vilaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Majem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lopez-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2024.100653_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.133645.111","article-title":"A\u00a0transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing","volume":"22","author":"Ju","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108344","article-title":"RET aberrant cancers and RET inhibitor therapies: current state-of-the-art and future perspectives","volume":"242","author":"Addeo","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jtocrr.2024.100653_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1200\/JCO.22.01644","article-title":"Selective targeting of RET fusions in lung cancer","volume":"41","author":"Lin","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jtho.2022.12.018","article-title":"RET-MAP: an international multicenter study on Clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion","volume":"18","author":"Aldea","year":"2023","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-023-00347-2","article-title":"Genomic landscape of 891 RET fusions detected across diverse solid tumor types","volume":"7","author":"Parimi","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jmoldx.2021.12.004","article-title":"Identification and validation of noncanonical RET fusions in non\u2013small-cell lung cancer through DNA and RNA sequencing","volume":"24","author":"Xiang","year":"2022","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jtocrr.2024.100653_bib10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1078-0432.CCR-20-3208","article-title":"A\u00a0performance comparison of commonly used assays to detect RET fusions","volume":"27","author":"Yang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12885-020-07714-3","article-title":"Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States","volume":"21","author":"Hess","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion\u2013positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4143\/crt.2023.403","article-title":"Expanded access program pralsetinib in advanced non\u2013small cell lung cancer with rearranged during transfection (RET) gene rearrangement","volume":"55","author":"Jeon","year":"2023","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jtocrr.2024.100653_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211019675","article-title":"Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program","volume":"13","author":"Illini","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2005653","article-title":"Efficacy of selpercatinib in RET fusion\u2013positive non\u2013small-cell lung cancer","volume":"383","author":"Drilon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1470-2045(21)00247-3","article-title":"Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1\/2 study","volume":"22","author":"Gainor","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib17","article-title":"Selpercatinib shifts treatment paradigm for MTC and NSCLC","volume":"13","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtocrr.2024.100653_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.22.00393","article-title":"Selpercatinib in patients with RET fusion\u2013positive non\u2013small-cell lung cancer: updated safety and efficacy from the registrational LIBRETTO-001 phase I\/II trial","volume":"41","author":"Drilon","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.annonc.2022.08.002","article-title":"Safety and efficacy of pralsetinib in RET fusion\u2013positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial","volume":"33","author":"Griesinger","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/oncolo\/oyac264","article-title":"RET fusion-positive non-small cell lung cancer: the evolving treatment landscape","volume":"28","author":"Novello","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jtocrr.2024.100653_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib22","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41591-022-01931-y","article-title":"Pan-cancer efficacy of pralsetinib in patients with RET fusion\u2013positive solid tumors from the phase 1\/2 ARROW trial","volume":"28","author":"Subbiah","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1470-2045(22)00556-3","article-title":"Tissue-agnostic RET inhibition: can you trust your target?","volume":"23","author":"D\u2019Aiello","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib24","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMe2311331","article-title":"Thirty years of progress thanks to the RET oncogene","volume":"389","author":"Castinetti","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.562480","article-title":"Practical considerations relating to routine clinical biomarker testing for non\u2013small cell lung cancer: focus on testing for RET fusions","volume":"7","author":"Herbst","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.annonc.2020.11.021","article-title":"ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research","volume":"32","author":"Belli","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib27","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1111\/1759-7714.15105","article-title":"Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China","volume":"14","author":"Pu","year":"2023","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib28","article-title":"Impact of clinical practice gaps on the implementation of personalized medicine in advanced non\u2013small-cell lung cancer","volume":"6","author":"Sadik","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/arpa.2022-0443-OA","article-title":"Efficient identification of patients with NTRK fusions using a supervised tumor-agnostic approach","volume":"148","author":"Hernandez","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107200","article-title":"Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry","volume":"9","author":"Conde","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtocrr.2024.100653_bib31","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jtho.2019.07.005","article-title":"Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non\u2013small cell lung carcinoma: the ROSING study","volume":"14","author":"Conde","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jtho.2021.01.1619","article-title":"RET fluorescence in situ hybridization analysis is a sensitive but highly unspecific screening method for RET fusions in lung cancer","volume":"16","author":"Radonic","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5858\/arpa.2020-0376-OA","article-title":"Analytical accuracy of RET fusion detection by break-apart fluorescence in situ hybridization","volume":"146","author":"Baker","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.lungcan.2020.10.012","article-title":"Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)","volume":"152","author":"Griesinger","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib35","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.3390\/curroncol29070352","article-title":"Upfront next generation sequencing in non-small cell lung cancer","volume":"29","author":"Kuang","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/oncolo\/oyac035","article-title":"Targeted next-generation sequencing reveals exceptionally high rates of molecular driver mutations in never-smokers with lung adenocarcinoma","volume":"27","author":"Mack","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.jtocrr.2024.100653_bib37","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.cllc.2022.09.010","article-title":"Real-world ALK testing trends in patients with advanced non\u2013small-cell lung cancer in the United States","volume":"24","author":"Lin","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib38","article-title":"Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtocrr.2024.100653_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cllc.2023.03.002","article-title":"Real-world biomarker testing patterns in patients with metastatic non-squamous non-small cell lung cancer (NSCLC) in a US community-based oncology practice setting","volume":"24","author":"Sireci","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2022.09.005","article-title":"Access and quality of biomarker testing for precision oncology in Europe","volume":"176","author":"Normanno","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib42","article-title":"Biomarker testing for patients with advanced\/metastatic nonsquamous NSCLC in the United States of America, 2015 to 2021","volume":"3","author":"Hess","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2024.100653_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2017.76.7293","article-title":"Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the college of American pathologists\/ international association for the","volume":"36","author":"Kalemkerian","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib44","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung ACs with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib45","article-title":"Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement","volume":"35","author":"Gao","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.jtocrr.2024.100653_bib46","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jtho.2020.08.011","article-title":"Molecular characterization and clinical outcomes in RET-rearranged NSCLC","volume":"15","author":"Tan","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.21037\/tlcr-22-202","article-title":"Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients","volume":"11","author":"Feng","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lungcan.2016.09.002","article-title":"Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma","volume":"101","author":"Song","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-022-00325-0","article-title":"Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling","volume":"6","author":"Wang","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib50","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.2016.70.9352","article-title":"Targeting RET in patients with RET -Rearranged lung cancers: results from the global, multicenter RET registry","volume":"35","author":"Gautschi","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.864367","article-title":"The treatment status of\u00a0patients in NSCLC with RET fusion under the prelude\u00a0of selective RET-TKI application in China: a multicenter retrospective research","volume":"12","author":"Meng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66883-0","article-title":"Unique genetic characteristics and clinical prognosis of female patients with lung cancer harboring RET fusion gene","volume":"10","author":"Qiu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtocrr.2024.100653_bib53","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/bjc.2014.36","article-title":"RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis","volume":"110","author":"Tsuta","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lungcan.2022.11.005","article-title":"Pralsetinib in RET fusion-positive non-small-cell lung cancer: a real-world data (RWD) analysis from the Italian expanded access program (EAP)","volume":"174","author":"Passaro","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2022.02.005","article-title":"The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies\u2019 integration","volume":"123","author":"Ambrosini-Spaltro","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib56","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jtho.2021.03.021","article-title":"Break-apart fluorescence in situ hybridization probe requires proper interpretation criteria","volume":"16","author":"Uguen","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/cells12081135","article-title":"Gene fusion detection in NSCLC routine clinical practice: targeted-NGS or FISH?","volume":"12","author":"Pecciarini","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jtocrr.2024.100653_bib58","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.21037\/tlcr-22-855","article-title":"A\u00a0narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma","volume":"12","author":"Hernandez","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2024.100653_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2014.02.007","article-title":"ALK, ROS1 and RET fusions in 1139 lung ACs: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features","volume":"84","author":"Pan","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jtho.2015.09.016","article-title":"Clinicopathological characteristics of RET rearranged lung cancer in European patients","volume":"11","author":"Michels","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib62","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/modpathol.2014.107","article-title":"Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma","volume":"28","author":"Lee","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib63","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2012.44.1477","article-title":"RET fusions define a unique molecular and clinicopathologic subtype of non\u2013small-cell lung cancer","volume":"30","author":"Wang","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/EDBK_237863","article-title":"Biomarker testing for patients with advanced non\u2013small cell lung cancer: real-world issues and tough choices","volume":"39","author":"Pennell","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jtocrr.2024.100653_bib65","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/JTO.0000000000000135","article-title":"Molecular mechanisms underlying oncogenic RET fusion in lung AC","volume":"9","author":"Mizukami","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2019.11.022","article-title":"Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: incremental yield of actionable alterations and cost-effectiveness analysis","volume":"139","author":"Tan","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.6004\/jnccn.2021.7120","article-title":"Economic analysis of exclusionary EGFR test versus up-front NGS for lung adenocarcinoma in high EGFR mutation prevalence areas","volume":"20","author":"Yang","year":"2022","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jtocrr.2024.100653_bib68","article-title":"Clinical and economic impact of upfront next-generation sequencing for metastatic NSCLC in East Asia","volume":"3","author":"Loong","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2024.100653_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101586","article-title":"Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group","volume":"8","author":"Loong","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtocrr.2024.100653_bib70","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/JTO.0000000000000323","article-title":"RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib","volume":"9","author":"Mukhopadhyay","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2024.100653_bib71","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1158\/1078-0432.CCR-12-0838","article-title":"Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions","volume":"18","author":"Suehara","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib72","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/cncr.27940","article-title":"KIF5B-RET fusions in Chinese patients with non-small cell lung cancer","volume":"119","author":"Cai","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jtocrr.2024.100653_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3727\/096504018X15344979253618","article-title":"Clinical characteristics and molecular patterns of RET-rearranged lung cancer in Chinese patients","volume":"27","author":"Zhang","year":"2019","journal-title":"Oncol Res"},{"key":"10.1016\/j.jtocrr.2024.100653_bib74","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/cancers12030693","article-title":"Imaging features and patterns of metastasis in non-small cell lung cancer with RET rearrangements","volume":"12","author":"Digumarthy","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364324000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364324000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:36:34Z","timestamp":1714808194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364324000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666364324000237"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2024.100653","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RET Fusion Testing in Patients With NSCLC: The RETING Study","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2024.100653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100653"}}